Sterility Test of Reconstituted Ganciclovir Solution for Injection
Keywords:
Ganciclovir injection, Sterility testAbstract
Background: Ganciclovir is an antiviral medication used to treat and prevent of cytomegalovirus (CMV) infection. The manufacturer recommended using it within 24 hours after dilution to reduce the risk of bacterial contamination. However, the dosage used for infant with infection at the Queen Sirikit National Institute of Child Health involves small amounts of the drug, resulting in a large amount of leftover medication. Therefore, a study was conducted to examine the stability of the drug after dilution to extend its shelf life and reduce the loss of drug value. Objective: To study the sterility of the preparation of ganciclovir injection at concentration 5 mg/ml Method: This is an experimental study preparing in a negative pressure isolator inside a cleanroom. Ganciclovir 500 mg was dissolved in 10 ml of sterile water for injection, then further diluted in normal saline for injection up to 100 ml final concentration of 5 mg/ml. The solution was stored in polypropylene bags, sealed with parafilm, and in polypropylene syringes placed in sterile peel pouches. It was stored at temperature 2-8 °C. Sterility was tested using the direct inoculation method, the pH of the solution was measured with a pH meter, and the physical stability was observed visually on days 0, 7, 14, 21, 28, and 35 after preparation. Result: The ganciclovir injection at concentration 5 mg/ml in normal saline solution (NSS) remained free from bacterial, yeast, and mold growth over the 35 days period. The pH value ranged from 10.10 to 10.19, and the physical appearance did not change from the freshly prepared solution. Conclusion: The ganciclovir injection at concentration 5 mg/ml in NSS was prepared in a negative pressure isolator, set up inside a cleanroom. The solution was stored at temperature 2-8 °C in a polypropylene bags or syringe, remaining sterile for at least 35 days.
References
Ganciclovir (Systemic). In: Lexi-drugs online [Internet]. Waltham (MA): UpToDate Inc .; 2024 [cited 2024 Sep 24]. Available from: http://online.lexi.com
United States Pharmacopeial Convention Inc. United States Pharmacopeia 41-the National Formulary 36. Rockville: United States Pharmacopeial Convention Inc; 2018.
Cytovene® [package insert]. Germany (Greifswald): CHEPLAPHARM Arzneimittel GmbH; 2018.
Mole L, Oliva C, O'Hanley P. Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis. J Acquir Immune Defic Syndr (1988) 1992;5(4):354-8.
Trissel LA. Handbook on injectable drug. 15th ed. Bethesda: American society of health-system pharmacist; 2009. p. 702-3.
KNUDSEN LF. Sample size of parenteral solutions for sterility testing. J Am Pharm Assoc Am Pharm Assoc 1949;38(6):332-7
National Institute of Health. Laboratory manual for bacteriology and fungi for regional and general hospitals 2018. Nonthaburi: Department of Medical Sciences, Ministry of Public Health; 2018: p.268-77.
Therapeutic Goods Administration. TGA guidelines for sterility testing of therapeutic goods. Australia: the Australian Government Department of Health and Ageing; 2006: p. 15.
Thai Pharmacopoeia. Thai Pharmacopoeia and Reference Substances Section Bureau of Drug and Narcotic Department of Medical Sciences. Volume I and II Supplement. Nonthaburi: Thai Pharmacopoeia; 2005.
Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S. Long-term stability of ganciclovir in polypropylene containers at room temperature. J Oncol Pharm Pract 2017:1078155217732629.
Okumura N, Tanaka T, Fukui Y, Koizumi N. Stability, safety, and pharmacokinetics of ganciclovir eye drops prepared from ganciclovir for intravenous infusion. Jpn J Ophthalmo 2019;63(3):289-96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Department of Medical Services, Ministry of Public Health

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของกรมการแพทย์ กระทรวงสาธารณสุข
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์